Release of signal peptide fragments into the cytosol requires cleavage in the transmembrane region by a protease activity that is specifically blocked by a novel cysteine protease inhibitor

被引:108
作者
Weihofen, A [1 ]
Lemberg, MK [1 ]
Ploegh, HL [1 ]
Bogyo, M [1 ]
Martoglio, B [1 ]
机构
[1] ETH Zentrum, Inst Biochem, CH-8092 Zurich, Switzerland
关键词
D O I
10.1074/jbc.M005980200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signal peptides of secretory and membrane proteins are generated by proteolytic processing of precursor proteins after insertion into the endoplasmic reticulum membrane. Liberated signal peptides can be further processed, and the resulting N-terminal fragments are released toward the cytosol, where they may interact with target proteins like calmodulin. We show here that the processing of signal peptides requires a protease activity distinct from signal peptidase, This activity is inhibited specifically with a newly developed cysteine protease inhibitor, 1,3-di-(N-carboxybenzoyl-L-leucyl-L-leucyl)amino acetone ((Z-LL)(2) ketone). Inhibitor studies revealed that the final, (Z-LL)(2) ketone sensitive cleavage event occurs within the hydrophobic transmembrane region of the signal peptide, thus promoting the release of an N-terminal fragment into the cytosol.
引用
收藏
页码:30951 / 30956
页数:6
相关论文
共 33 条
  • [1] Identification and characterization of a determinant (eep) on the Enterococcus faecalis chromosome that is involved in production of the peptide sex pheromone cAD1
    An, FY
    Sulavik, MC
    Clewell, DB
    [J]. JOURNAL OF BACTERIOLOGY, 1999, 181 (19) : 5915 - 5921
  • [2] Bai AL, 1997, J IMMUNOL, V159, P2139
  • [3] Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors
    Bogyo, M
    McMaster, JS
    Gaczynska, M
    Tortorella, D
    Goldberg, AL
    Ploegh, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) : 6629 - 6634
  • [4] Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
    Borrego, F
    Ulbrecht, M
    Weiss, EH
    Coligan, JE
    Brooks, AG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) : 813 - 818
  • [5] The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9
    Braud, V
    Jones, EY
    McMichael, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) : 1164 - 1169
  • [6] HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
    Braud, VM
    Allan, DSJ
    O'Callaghan, CA
    Söderström, K
    D'Andrea, A
    Ogg, GS
    Lazetic, S
    Young, NT
    Bell, JI
    Phillips, JH
    Lanier, LL
    McMichael, AJ
    [J]. NATURE, 1998, 391 (6669) : 795 - 799
  • [7] The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
    Brown, MS
    Goldstein, JL
    [J]. CELL, 1997, 89 (03) : 331 - 340
  • [8] Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans
    Brown, MS
    Ye, J
    Rawson, RB
    Goldstein, JL
    [J]. CELL, 2000, 100 (04) : 391 - 398
  • [9] GILMORE R, 1991, METHOD CELL BIOL, V34, P223
  • [10] BiP maintains the permeability barrier of the ER membrane by sealing the lumenal end of the translocon pore before and early in translocation
    Hamman, BD
    Hendershot, LM
    Johnson, AE
    [J]. CELL, 1998, 92 (06) : 747 - 758